NCT03873337View on ClinicalTrials.gov

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

January 10, 2022

Study Completion Date

January 31, 2022

Conditions
Tobacco UseTobacco SmokingTobacco Use CessationTobacco Use DisorderSchizophreniaSchizoaffective Disorder
Interventions
BEHAVIORAL

Persistence Targeted Smoking Cessation in SMI (PTSC-S)

All participants will receive 8 weeks of persistence focused smoking cessation counseling delivered via telehealth

DRUG

Nicotine patch

All participants will receive 10 weeks of nicotine patch

Trial Locations (1)

08901

Division of Addiction Psychiatry, New Brunswick

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Rutgers, The State University of New Jersey

OTHER

NCT03873337 - Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) | Biotech Hunter | Biotech Hunter